Overview

Study of Whether 15 mg Dose of Ketorolac IV is as Effective as a 30 mg Dose.

Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to show the non-inferiority of 15 mg intraoperative dose of ketorolac as compared to the standard 30 mg ketorolac by looking at the VAS scores 4 hours after an adult spine surgery.
Phase:
N/A
Details
Lead Sponsor:
University of Calgary
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Ketorolac
Ketorolac Tromethamine